Mirum Pharmaceuticals Provides Enrollment Update for AZURE Clinical Program of Brelovitug in Chronic Hepatitis Delta Virus

Mirum Pharmaceuticals
Mirum Pharmaceuticals (MIRM) is a leading rare disease company with a global footprint of approved products and a broad pipeline of investigational medicines. Purpose-built to bring forward breakthrough medicines for people with overlooked conditions, Mirum combines deep rare disease expertise with strong connections to patient communities.
From the Experts

Tatyana Kushner, M.D., MSCE, Associate Professor of . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.